DVA

$187.753.07%5.5843

Nachbörslich: 182.17-5.58 -2.97%

Davita Inc (DVA)

Date: O: H: L: C: Vol:

Schlusskurs vom Vortag:

$182.17

Offen:

$185.52

24-Stunden-Volumen:

188,302

Relatives Volumen:

0.19

Marktkapitalisierung:

$11.81B

Einnahmen:

$13.84B

Nettoeinkommen (Verlust:

$1.10B

KGV:

18.02

EPS:

$10.42

Netto-Cashflow:

$1.49B

1W Leistung:

+2.08%

1M Leistung:

+5.07%

6M Leistung:

+21.86%

1Y Leistung:

+56.50%

1-Tages-Spanne:

$185.51$189.78

1-Wochen-Bereich:

$171.15$196.97

52-Wochen-Spanne:

$101.00$247.49

Davita Inc Aktie (DVA) Unternehmensprofil

Firmenname

Davita Inc

Sektor

Healthcare

Branche

Medical Care Facilities

Telefon

310-536-2668

Adresse

2000 16TH STREET, DENVER, CO, USA

Mitarbeiter

78,000

@DaVita

Nächster Verdiensttermin

null

Neueste SEC-Einreichungen

SEC

DVA-Diskussionen auf X

Marktkapitalisierung

Umsatz

Nettogewinn

Free Cashflow

ENV

Davita Inc Aktie (DVA) Hochstufungen & Herabstufungen

Datum	Aktion	Analytiker	Ratingänderung
2026-08-07	Hochstufung	TD Cowen	Hold → Buy
2026-05-06	Hochstufung	Deutsche Bank	Hold → Buy
2024-03-06	Eingeleitet	Barclays	Equal Weight
2023-08-07	Hochstufung	UBS	Neutral → Buy
2022-11-01	Herabstufung	Deutsche Bank	Buy → Hold
2022-10-31	Herabstufung	UBS	Buy → Neutral
2022-08-19	Resumed	UBS	Buy
2022-06-21	Bestätigt	BofA Securities	Underperform
2021-09-10	Eingeleitet	Cowen	Market Perform
2021-08-12	Herabstufung	Barclays	Overweight → Equal Weight
2021-03-26	Herabstufung	BofA Securities	Neutral → Underperform
2021-01-05	Herabstufung	BofA Securities	Buy → Neutral
2020-01-24	Hochstufung	Goldman	Neutral → Buy
2019-11-07	Herabstufung	Raymond James	Outperform → Mkt Perform
2019-10-25	Herabstufung	Wolfe Research	Outperform → Peer Perform
2019-09-11	Herabstufung	William Blair	Outperform → Mkt Perform
2019-07-26	Herabstufung	Robert W. Baird	Outperform → Neutral
2019-01-08	Hochstufung	UBS	Sell → Neutral
2019-01-03	Eingeleitet	Deutsche Bank	Buy
2018-12-14	Eingeleitet	Barclays	Overweight
2018-11-28	Hochstufung	Raymond James	Mkt Perform → Outperform
2018-11-16	Eingeleitet	UBS	Sell
2018-11-08	Herabstufung	Raymond James	Strong Buy → Mkt Perform
2018-09-13	Hochstufung	JP Morgan	Underweight → Neutral
2018-01-04	Hochstufung	BofA/Merrill	Neutral → Buy
2017-12-12	Hochstufung	Robert W. Baird	Neutral → Outperform
2017-12-11	Hochstufung	Citigroup	Neutral → Buy
2017-12-07	Hochstufung	Raymond James	Outperform → Strong Buy
2017-11-08	Bestätigt	RBC Capital Mkts	Sector Perform
2017-10-09	Herabstufung	JP Morgan	Neutral → Underweight
2017-06-26	Herabstufung	Jefferies	Buy → Hold
2016-12-13	Herabstufung	Robert W. Baird	Outperform → Neutral

Finanzdaten der Davita Inc-Aktie (DVA)

Zeitraum	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Enddatum des Zeitraums	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue USD (M)	13,643.07	12,815.55	12,140.15	11,609.89	11,618.80
Operating expenses USD (M)	11,599.45	10,725.07	10,537.36	10,270.83	9,821.43
Operating income USD (M)	2,043.62	2,090.48	1,602.78	1,339.06	1,797.37
Income before tax USD (M)	1,346.82	1,530.39	1,177.09	966.28	1,518.49
Income tax expense USD (M)	293.11	279.66	220.12	198.09	306.73
Net income USD (M)	1,078.72	1,250.74	956.98	781.64	1,211.76
Basic EPS USD/shares	10.06	11.02	7.62	6.03	9.30
Diluted EPS USD/shares	9.84	10.73	7.42	5.85	8.90
Basic weighted shares shares (M)	74.23	84.99	90.79	92.99	105.23
Diluted weighted shares shares (M)	75.89	87.27	93.18	95.83	109.95

Davita Inc-Aktie (DVA) Insiderhandel

BERKSHIRE HATHAWAY INCOct 27 '26
10% Owner
Transaktion
Sale
Kosten
$180.43
#Aktien
382,563
Wert ($)
69,026,033
#Aktien Gesamt
28,314,666
BERKSHIRE HATHAWAY INCJul 31 '26
10% Owner
Transaktion
Sale
Kosten
$199.55
#Aktien
182,980
Wert ($)
36,513,293
#Aktien Gesamt
28,697,229
Javier RodgriguezJun 16 '26
Officer
Transaktion
Proposed Sale
Kosten
$209.28
#Aktien
39,407
Wert ($)
8,247,016
#Aktien Gesamt
0
Rodriguez JavierJun 16 '26
Chief Executive Officer
Transaktion
Sale
Kosten
$209.28
#Aktien
39,407
Wert ($)
8,247,018
#Aktien Gesamt
840,408
Waters Kathleen AlyceJun 15 '26
Officer
Transaktion
Proposed Sale
Kosten
$207.93
#Aktien
6,455
Wert ($)
1,342,188
#Aktien Gesamt
0
Waters Kathleen AlyceJun 15 '26
Chief Legal & Pub. Affairs Off
Transaktion
Sale
Kosten
$208.40
#Aktien
15,405
Wert ($)
3,210,377
#Aktien Gesamt
109,194
Rodriguez JavierJun 15 '26
Chief Executive Officer
Transaktion
Sale
Kosten
$209.50
#Aktien
30,000
Wert ($)
6,285,090
#Aktien Gesamt
879,815
Kathleen WatersJun 15 '26
Officer
Transaktion
Proposed Sale
Kosten
$207.84
#Aktien
8,950
Wert ($)
1,860,202
#Aktien Gesamt
0
Javier RodriguezJun 15 '26
Officer
Transaktion
Proposed Sale
Kosten
$209.50
#Aktien
30,000
Wert ($)
6,285,102
#Aktien Gesamt
0
HEARTY JAMES OMay 15 '26
Chief Compliance Officer
Transaktion
Sale
Kosten
$193.98
#Aktien
15,000
Wert ($)
2,909,745
#Aktien Gesamt
22,389

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
BERKSHIRE HATHAWAY INC	10% Owner	Oct 27 '26	Sale	$180.43	382,563	69,026,033	28,314,666
BERKSHIRE HATHAWAY INC	10% Owner	Jul 31 '26	Sale	$199.55	182,980	36,513,293	28,697,229
Javier Rodgriguez	Officer	Jun 16 '26	Proposed Sale	$209.28	39,407	8,247,016	0
Rodriguez Javier	Chief Executive Officer	Jun 16 '26	Sale	$209.28	39,407	8,247,018	840,408
Waters Kathleen Alyce	Officer	Jun 15 '26	Proposed Sale	$207.93	6,455	1,342,188	0
Waters Kathleen Alyce	Chief Legal & Pub. Affairs Off	Jun 15 '26	Sale	$208.40	15,405	3,210,377	109,194
Rodriguez Javier	Chief Executive Officer	Jun 15 '26	Sale	$209.50	30,000	6,285,090	879,815
Kathleen Waters	Officer	Jun 15 '26	Proposed Sale	$207.84	8,950	1,860,202	0
Javier Rodriguez	Officer	Jun 15 '26	Proposed Sale	$209.50	30,000	6,285,102	0
HEARTY JAMES O	Chief Compliance Officer	May 15 '26	Sale	$193.98	15,000	2,909,745	22,389

Davita Inc Aktie (DVA) Neueste Nachrichten

05:19 AM

3 AllianceBernstein Mutual Funds for Long-Term Returns - Zacks Investment Research

05:19 AM

Nov 02, 2026

Bronstein, Gewirtz & Grossman, LLC Encourages DaVita Inc. (DVA) S - The National Law Review

Nov 02, 2026

UBS raises DaVita stock price target to $287 on reimbursement outlook - Investing.com Canada

Nov 02, 2026

Oct 30, 2026

DaVita Q3 Earnings Beat Estimates on IKC Strength, Revenues Rise Y/Y - Zacks Investment Research

Oct 30, 2026

DaVita Q3 Earnings Beat Estimates on IKC Strength, Revenues Rise Y/Y - TradingView

Oct 30, 2026

DaVita Inc. (DVA) Seasonal Returns Chart - Yahoo Finance - Yahoo! Finance Canada

Oct 29, 2026

Earnings call transcript: DaVita beats Q3 2026 estimates but stock falls after hours - Investing.com

Oct 29, 2026

DaVita Inc Reports Q3 2026 Revenue of $3.578 Billion, GAAP EPS o - GuruFocus

Oct 29, 2026

DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch

Oct 29, 2026

DaVita’s (NYSE:DVA) Q3 2026: beats on revenue but stock drops - FinancialContent

Oct 29, 2026

Earnings Flash (DVA) DaVita Inc. Posts Q3 Adjusted EPS $3.82 per Share, vs. FactSet Est of $3.57 - www.marketscreener.com

Oct 29, 2026

DaVita Inc. 3rd Quarter 2026 Results - TradingView

Oct 29, 2026

DaVita Inc. 3rd Quarter 2026 Results - Porterville Recorder

Oct 29, 2026

DaVita Inc. (DVA) Posts Q3 Results; Takes $62M Impairment, Buys Back $111M Stock - TradingView

Oct 29, 2026

DaVita earnings on deck as regulatory scrutiny intensifies - Investing.com

Oct 29, 2026

Oct 28, 2026

DaVita earnings: what to look for from DVA - Yahoo Finance

Oct 28, 2026

Oct 27, 2026

DaVita settles ADA complaint with Lexington patient - WKYT

Oct 27, 2026

Will DaVita's Q3 Earnings Reflect Improving Treatment Growth Trends? - Zacks Investment Research

Oct 27, 2026

Will DaVita's Q3 Earnings Reflect Improving Treatment Growth Trends? - TradingView

Oct 27, 2026

DaVita Brings Preventive Health Screenings Into Communities to Help Identify Hidden Health Risks - PR Newswire

Oct 27, 2026

Oct 25, 2026

How Investors Are Reacting To DaVita (DVA) Kidney Week Research Push - Yahoo Finance

Oct 25, 2026

Oct 24, 2026

DaVita Inc. (DVA) Stock Forecasts - Yahoo! Finance Canada

Oct 24, 2026

Oct 23, 2026

DaVita Inc. stock outperforms competitors despite losses on the day - MarketWatch

Oct 23, 2026

DaVita HealthCare (DVA) Falls More Steeply Than Broader Market: What Investors Need to Know - Zacks Investment Research

Oct 23, 2026

DaVita Inc. Estimates – NYSE:DVA - TradingView

Oct 23, 2026

Oct 22, 2026

DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch

Oct 22, 2026

DaVita Stock Gains 55.6% Year to Date: What's Behind the Rally? - Zacks Investment Research

Oct 22, 2026

DaVita Stock Gains 55.6% Year to Date: What's Behind the Rally? - TradingView

Oct 22, 2026

DaVita Earnings Preview: What to Expect - Barchart.com

Oct 22, 2026

DaVita Inc. (DVA) Stock Forecasts - Yahoo Finance

Oct 22, 2026

Oct 21, 2026

HHS Kidney Care Plan Raises Concerns for DaVita (DVA) Amid Positive Analyst Outlook - GuruFocus

Oct 21, 2026

Oct 20, 2026

DaVita Responds to HHS Kidney Care National Plan, Reaffirms Commitment to Innovation, Access and Patient Choice - PR Newswire

Oct 20, 2026

DaVita Inc. (DVA) Stock Forecasts - Yahoo Finance

Oct 20, 2026

A Look at DaVita Inc (DVA) After 6.2% Decline -- GF Value $198.0 - GuruFocus

Oct 20, 2026

Why DaVita (DVA) Stock Is Nosediving - Yahoo Finance

Oct 20, 2026

Why DaVita (DVA) Stock Is Nosediving - TradingView

Oct 20, 2026

DaVita falls 6% amid proposed kidney care plan (DVA:NYSE) - Seeking Alpha

Oct 20, 2026

DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Oct 20, 2026

HHS Launches Kidney Care National Plan, Impacting DaVita Inc (DV - GuruFocus

Oct 20, 2026

DaVita (DVA) Shares Slip Amid Trump Administration Dialysis Mark - GuruFocus

Oct 20, 2026

DaVita, Fresenius drop as HHS seeks dialysis market reforms (DVA:NYSE) - Seeking Alpha

Oct 20, 2026

Oct 19, 2026

DaVita Inc. Schedules 3rd Quarter 2026 Investor Conference Call - The Napa Valley Register

Oct 19, 2026

DaVita $15 Million Data Breach Class Action Settlement - Claim Depot

Oct 19, 2026

DaVita Inc. Schedules 3rd Quarter 2026 Investor Conference Call - DaVita Newsroom

Oct 19, 2026

Oct 16, 2026

DaVita HealthCare (DVA) Stock Moves -1.01%: What You Should Know - Zacks Investment Research

Oct 16, 2026

DaVita HealthCare (DVA) Stock Moves -1.01%: What You Should Know - Yahoo Finance

Oct 16, 2026

Ähnlich wie DVA

Davita Inc (DVA)

Davita Inc Aktie (DVA) Unternehmensprofil

Marktkapitalisierung

Umsatz

Nettogewinn

Free Cashflow

ENV

Davita Inc Aktie (DVA) Hochstufungen & Herabstufungen

Finanzdaten der Davita Inc-Aktie (DVA)

Davita Inc-Aktie (DVA) Insiderhandel

Davita Inc Aktie (DVA) Neueste Nachrichten

3 AllianceBernstein Mutual Funds for Long-Term Returns - Zacks Investment Research

Bronstein, Gewirtz & Grossman, LLC Encourages DaVita Inc. (DVA) S - The National Law Review

UBS raises DaVita stock price target to $287 on reimbursement outlook - Investing.com Canada

DaVita Q3 Earnings Beat Estimates on IKC Strength, Revenues Rise Y/Y - Zacks Investment Research

DaVita Q3 Earnings Beat Estimates on IKC Strength, Revenues Rise Y/Y - TradingView

DaVita Inc. Q3 2026 Earnings Call Summary - Yahoo Finance

What DaVita (DVA) Said on Its Q3 Earnings Call - TradingView

DaVita Inc (DVA) (Q3 2026) Earnings Call Highlights: IKC Guidanc - GuruFocus

DaVita Inc. (DVA) Stock Forecasts - Yahoo Finance

DaVita Inc. (DVA) Seasonal Returns Chart - Yahoo Finance - Yahoo! Finance Canada

Earnings call transcript: DaVita beats Q3 2026 estimates but stock falls after hours - Investing.com

DaVita Inc Reports Q3 2026 Revenue of $3.578 Billion, GAAP EPS o - GuruFocus

DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch

DaVita’s (NYSE:DVA) Q3 2026: beats on revenue but stock drops - FinancialContent

Earnings Flash (DVA) DaVita Inc. Posts Q3 Adjusted EPS $3.82 per Share, vs. FactSet Est of $3.57 - www.marketscreener.com

DaVita Inc. 3rd Quarter 2026 Results - TradingView

DaVita Inc. 3rd Quarter 2026 Results - Porterville Recorder

DaVita Inc. (DVA) Posts Q3 Results; Takes $62M Impairment, Buys Back $111M Stock - TradingView

DaVita earnings on deck as regulatory scrutiny intensifies - Investing.com

DaVita earnings: what to look for from DVA - Yahoo Finance

DaVita settles ADA complaint with Lexington patient - WKYT

Will DaVita's Q3 Earnings Reflect Improving Treatment Growth Trends? - Zacks Investment Research

Will DaVita's Q3 Earnings Reflect Improving Treatment Growth Trends? - TradingView

DaVita Brings Preventive Health Screenings Into Communities to Help Identify Hidden Health Risks - PR Newswire

How Investors Are Reacting To DaVita (DVA) Kidney Week Research Push - Yahoo Finance

DaVita Inc. (DVA) Stock Forecasts - Yahoo! Finance Canada

DaVita Inc. stock outperforms competitors despite losses on the day - MarketWatch

DaVita HealthCare (DVA) Falls More Steeply Than Broader Market: What Investors Need to Know - Zacks Investment Research

DaVita Inc. Estimates – NYSE:DVA - TradingView

DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch

DaVita Stock Gains 55.6% Year to Date: What's Behind the Rally? - Zacks Investment Research

DaVita Stock Gains 55.6% Year to Date: What's Behind the Rally? - TradingView

DaVita Earnings Preview: What to Expect - Barchart.com

DaVita Inc. (DVA) Stock Forecasts - Yahoo Finance

HHS Kidney Care Plan Raises Concerns for DaVita (DVA) Amid Positive Analyst Outlook - GuruFocus

DaVita Responds to HHS Kidney Care National Plan, Reaffirms Commitment to Innovation, Access and Patient Choice - PR Newswire

DaVita Inc. (DVA) Stock Forecasts - Yahoo Finance

A Look at DaVita Inc (DVA) After 6.2% Decline -- GF Value $198.0 - GuruFocus

Why DaVita (DVA) Stock Is Nosediving - Yahoo Finance

Why DaVita (DVA) Stock Is Nosediving - TradingView

DaVita falls 6% amid proposed kidney care plan (DVA:NYSE) - Seeking Alpha

DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

HHS Launches Kidney Care National Plan, Impacting DaVita Inc (DV - GuruFocus

DaVita (DVA) Shares Slip Amid Trump Administration Dialysis Mark - GuruFocus

DaVita, Fresenius drop as HHS seeks dialysis market reforms (DVA:NYSE) - Seeking Alpha

DaVita Inc. Schedules 3rd Quarter 2026 Investor Conference Call - The Napa Valley Register

DaVita $15 Million Data Breach Class Action Settlement - Claim Depot

DaVita Inc. Schedules 3rd Quarter 2026 Investor Conference Call - DaVita Newsroom

DaVita HealthCare (DVA) Stock Moves -1.01%: What You Should Know - Zacks Investment Research

DaVita HealthCare (DVA) Stock Moves -1.01%: What You Should Know - Yahoo Finance

Ähnlich wie DVA